Sexual dysfunction and paraphilic risk — assessment and management (MEQ)

(i) Formulation. Medication-induced sexual dysfunction is likely: desire reduction and delayed ejaculation temporally linked to sertraline escalation, with remitted mood arguing against active melancholic anhedonia as the sole driver. This is a phase problem (desire + orgasm/ejaculation) with relationship impairment.[1][2][5]

Exhibitionistic urges plus acted exposures involving nonconsenting public victims meet the paraphilic disorder threshold (not mere atypical fantasy). Label exhibitionistic disorder; document frequency, escalation, planning, substances, and insight. Absence of pedophilic interest is noted but does not remove public-protection concerns from adult nonconsent exposures.[3][6]

(ii) Assessment priorities. Full sexual history (phases, lifelong/acquired, situational factors); depression relapse screen; suicide risk (passive death wishes with forensic fear — means, intent, protective factors, safety plan); substance use; detailed offence-analogue behaviours (times, locations, near-misses); access to victims; prior justice contact; personality/antisocial traits. Explain limits of confidentiality and jurisdiction-specific mandatory reporting/public interest disclosure duties when ongoing risk to others is identified. Collateral only with appropriate consent/legal pathway. Medical review as indicated before medication changes.[3][4][6]

(iii) Antidepressant-related SD management. Validate impact on adherence and relationship. Options: shared decision on continuing if depression risk high versus dose reduction (if safe), switch to a relatively lower sexual-side-effect agent (e.g. bupropion or mirtazapine where clinically appropriate and not contraindicated), or specialist adjunct strategies. Do not ignore symptoms because mood is remitted. Avoid nitrates/PDE5 confusion here — primary issue is serotonergic delay, not ED alone.[1][2][5]

(iv) Exhibitionistic disorder and risk. Immediate risk management: clear behavioural limits, remove opportunities where possible, crisis plan for urges, consider police/public-protection pathways as legally required, and specialist forensic/sex-offence psychology referral for offence-focused CBT/relapse prevention. Pharmacological drive reduction (SSRI strategies; antiandrogen/GnRH only in selected higher-risk specialist algorithms per WFSBP) is not a substitute for risk management or legal duties. Document decisions.[3][4][6]

(v) Disposition and safety-net. Closer follow-up while risk and medication changes are active; crisis contacts for suicidal ideation; written plan; involve forensic services early if available; do not offer false absolute confidentiality. Review sexual function after antidepressant change and monitor mood relapse. Escalate urgently if further exposures, stalking-equivalent behaviours, or suicidal intent emerges.[4][5]